Statement In Response To Texas Ruling Upending FDA Approval of Mifeprex®

Danco Laboratories Will Seek Stay While Immediately Appealing NEW YORK, April 7, 2023 /PRNewswire/ — Danco Laboratories strongly disagrees with unprecedented preliminary injunction issued by US District Judge Matthew Kacsmaryk in The Alliance for Hippocratic Medicine, et al., v. U.S….